Effect of pretreatment with P2Y12 receptor antagonists on mortality in patients undergoing PCI: A report from SCAAR

Gender differences in oral antiplatelet treatment use - results from a nationwide cohort study of acute coronary syndrome patients in Finland

Prevalence and outcomes of prasugrel versus clopidogrel in patients with and without diabetes following percutaneous coronary intervention for acute coronary syndrome

Platelet reactivity and outcomes after transcatheter aortic valve implantation

Safety of a regional standardized protocol to optimize the use of most effective platelet inhibition in ACS treated with PCI : Final Results from the Multicenter Rijnmond Collective Cardiology Study

Characteristics and safety outcomes in first-time users of the P2Y12 receptor antagonists clopidogrel, prasugrel and ticagrelor

Inter-individual variability and response to antiplatelet drugs: signalling pathway analysis

Switching from clopidogrel to prasugrel to protect early invasive treatment in acute coronary syndromes: results of the prospective randomized SWITCH OVER trial

Is there gender-related outcome difference with oral dual antiplatelet therapy in patients with acute coronary syndromes? A systematic review and meta-analysis.

One-year non-persistence with discharge P2Y12 receptor antagonists in acute coronary syndrome patients undergoing percutaneous coronary intervention:Insights into GReekAntiPlateletrEgistry (GRAPE).